BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 11606334)

  • 1. Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries.
    White R; Ho WS; Bottrill FE; Ford WR; Hiley CR
    Br J Pharmacol; 2001 Oct; 134(4):921-9. PubMed ID: 11606334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anandamide-induced relaxation of sheep coronary arteries: the role of the vascular endothelium, arachidonic acid metabolites and potassium channels.
    Grainger J; Boachie-Ansah G
    Br J Pharmacol; 2001 Nov; 134(5):1003-12. PubMed ID: 11682448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery.
    White R; Hiley CR
    Br J Pharmacol; 1997 Dec; 122(8):1573-84. PubMed ID: 9422801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of Delta9-tetrahydrocannabinol in rat mesenteric vasculature, and its interactions with the endocannabinoid anandamide.
    O'Sullivan SE; Kendall DA; Randall MD
    Br J Pharmacol; 2005 Jun; 145(4):514-26. PubMed ID: 15821751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of a novel site mediating anandamide-induced negative inotropic and coronary vasodilatator responses in rat isolated hearts.
    Ford WR; Honan SA; White R; Hiley CR
    Br J Pharmacol; 2002 Mar; 135(5):1191-8. PubMed ID: 11877326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelium-dependent mechanisms of the vasodilatory effect of the endocannabinoid, anandamide, in the rat pulmonary artery.
    Baranowska-Kuczko M; MacLean MR; Kozłowska H; Malinowska B
    Pharmacol Res; 2012 Sep; 66(3):251-9. PubMed ID: 22627170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasorelaxant activities of the putative endocannabinoid virodhamine in rat isolated small mesenteric artery.
    Ho WS; Hiley CR
    J Pharm Pharmacol; 2004 Jul; 56(7):869-75. PubMed ID: 15233865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.
    Herradón E; Martín MI; López-Miranda V
    Br J Pharmacol; 2007 Nov; 152(5):699-708. PubMed ID: 17704831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for N-arachidonylethanolamine (anandamide) as the mediator of sensory nerve-dependent Ca2+-induced relaxation.
    Ishioka N; Bukoski RD
    J Pharmacol Exp Ther; 1999 Apr; 289(1):245-50. PubMed ID: 10087011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery.
    Ho WS; Hiley CR
    Br J Pharmacol; 2003 Apr; 138(7):1320-32. PubMed ID: 12711633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid activation of recombinant and endogenous vanilloid receptors.
    Ralevic V; Kendall DA; Jerman JC; Middlemiss DN; Smart D
    Eur J Pharmacol; 2001 Jul; 424(3):211-9. PubMed ID: 11672565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteries.
    O'Sullivan SE; Kendall DA; Randall MD
    Br J Pharmacol; 2004 Jun; 142(3):435-42. PubMed ID: 15148250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Ca2+-dependent potassium channels in in vitro anandamide-mediated mesenteric vasorelaxation in rats with biliary cirrhosis.
    Yang YY; Lin HC; Huang YT; Lee TY; Hou MC; Wang YW; Lee FY; Lee SD
    Liver Int; 2007 Oct; 27(8):1045-55. PubMed ID: 17845532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anandamide elicits an acute release of nitric oxide through endothelial TRPV1 receptor activation in the rat arterial mesenteric bed.
    Poblete IM; Orliac ML; Briones R; Adler-Graschinsky E; Huidobro-Toro JP
    J Physiol; 2005 Oct; 568(Pt 2):539-51. PubMed ID: 16081483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor.
    Pratt PF; Hillard CJ; Edgemond WS; Campbell WB
    Am J Physiol; 1998 Jan; 274(1):H375-81. PubMed ID: 9458889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The endothelial component of cannabinoid-induced relaxation in rabbit mesenteric artery depends on gap junctional communication.
    Chaytor AT; Martin PE; Evans WH; Randall MD; Griffith TM
    J Physiol; 1999 Oct; 520 Pt 2(Pt 2):539-50. PubMed ID: 10523421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of vasorelaxant responses to anandamide in the rat mesenteric arterial bed.
    Harris D; McCulloch AI; Kendall DA; Randall MD
    J Physiol; 2002 Mar; 539(Pt 3):893-902. PubMed ID: 11897858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence against anandamide as the hyperpolarizing factor mediating the nitric oxide-independent coronary vasodilator effect of bradykinin in the rat.
    Fulton D; Quilley J
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1146-51. PubMed ID: 9732371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelium-independent relaxation to cannabinoids in rat-isolated mesenteric artery and role of Ca2+ influx.
    Ho WS; Hiley CR
    Br J Pharmacol; 2003 Jun; 139(3):585-97. PubMed ID: 12788818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
    Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
    Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.